ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,613.04
      -0.37%
      US Tech 100
      20,084.80
      -0.17%
      Dow Jones
      39,758.78
      0.09%
      Brent Oil
      84.555
      -0.58%
      Bitcoin
      57,735.62
      -0.02%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Obagi Medical Products, Inc. (MM) (OMPI) Quote

      Obagi Medical Products, Inc. (MM)

      Obagi Medical Products, Inc. (MM) (OMPI)

      NASDAQ
      23.98
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      23.98
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      23.98
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      OMPI Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

      2 hours ago
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KZIAKazia Therapeutics Ltd
      $ 1.34
      (100.54%)
      		113.48M
      LCFYLocafy Ltd
      $ 4.50
      (93.96%)
      		830.93k
      BDRXBiodexa Pharmaceuticals PLC
      $ 1.2239
      (72.11%)
      		45.83M
      ISPCiSpecimen Inc
      $ 0.4294
      (50.19%)
      		26.63M
      VLCNVolcon Inc
      $ 5.3786
      (47.36%)
      		19.59M
      IVPInspire Veterinary Partners Inc
      $ 5.53
      (-25.27%)
      		1.18M
      CINGCingulate Inc
      $ 0.489015
      (-24.53%)
      		708.07k
      CETUUCetus Capital Acquisition Corporation
      $ 7.58
      (-23.90%)
      		305
      SLRXSalarius Pharmaceuticals Inc
      $ 2.21
      (-19.42%)
      		1.64M
      TCTuanChe Ltd
      $ 1.56
      (-19.17%)
      		188.33k
      KZIAKazia Therapeutics Ltd
      $ 1.34
      (100.54%)
      		113.48M
      NVDANVIDIA Corporation
      $ 133.87
      (-0.77%)
      		63.84M
      RNLXRenalytix PLC
      $ 0.422
      (39.78%)
      		61.56M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.1977
      (-6.21%)
      		60.65M
      SOUNSoundHound AI Inc
      $ 6.085
      (20.02%)
      		50.44M

      OMPI Discussion

      View Posts
      BooDog BooDog 11 years ago
      Far out. Gives my little guys some hope
      congrats!!
      👍️0
      ospreyeye ospreyeye 11 years ago
      OMPI Chart.......Gapper.......huge move today...............$$$

      👍️0
      Edgenation Edgenation 12 years ago
      Ok just sold because of revenue/inventory numbers. I'll be back someday!
      👍️0
      Edgenation Edgenation 12 years ago
      Haha no, just saying that would be nice! but intermediate to long term there is a good chance. We shall see!
      👍️0
      mlkrborn mlkrborn 12 years ago
      In a week?
      GL
      mlkr
      👍️0
      Edgenation Edgenation 12 years ago
      Just got in today at $14.53. Pretty dead board but the company has great near term potential with a possible buyout still! hopefully this runs to $20 in a week!
      👍️0
      mlkrborn mlkrborn 12 years ago
      Obagi Medical: Addresses response by Obagi Board of Directors to its letter says 'Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers' (OMPI) 11.87 : The letter stated "On February 10, 2012, Voce sent a letter to the Obagi Board of Directors criticizing the Board's recent adoption of a poison pill and demanding immediate action to address corporate governance deficiencies and to evaluate strategic alternatives. Voce's letter stated that it believed Obagi has spurned recent overtures to acquire the Company. On February 14, 2012, the Obagi Board responded to Voce's letter. The Board's statement notably did not dispute Voce's claims that the Company had recently received and summarily rebuffed offers to acquire Obagi. In addition, the Obagi Board's response states in part: Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers from this point forward will be reviewed by these independent advisors. Voce believes that this change in Obagi's posture may invite additional acquisition interest....There is substantial strategic interest in an acquisition of Obagi and broad support for a sale of the Company in both the investment and the analyst community. It behooves the Obagi Board to pursue this potential outcome diligently."
      👍️0
      mlkrborn mlkrborn 15 years ago
      Too bad no one covered but up since its creation: Chart!
      http://stockcharts.com/h-sc/ui?s=ompi&p=D&yr=0&mn=6&dy=0&id=p97690170109
      👍️0
      kmx_swing kmx_swing 16 years ago
      OMPI board created
      👍️0

      Your Recent History

      NASDAQ
      OMPI
      BIT
      XDEQ
      Xtrackers Msci World Qua...
      Delayed Upgrade Clock